| 摘要: |
| 随着我国经济发展和医学进步，在我国开展药物临床试验的数量与日俱增，对于规范药物临床试验，我国虽已取得不错的成就，但尚存有一定不足。本文从法律视角，总结我国在规范药物临床试验方面已走过的历程，分析目前尚存在的不足，并提出相应改善建议，以期为进一步规范临床试验及保护受试者的合法权益提供参考。 |
| 关键词: 药物临床试验 受试者权益 法律 |
| DOI： |
|
| 基金项目: |
|
| Study on the Protection of Human Subjects’ Rights and Interests in Drug Clinical Trials in China from the Perspective of Law |
|
| () |
| Abstract: |
| With the development of economy and medicine, the number of drug clinical trials is increasing gradually in China. Great achievements have been achieved in regulating clinical trials, but there are still some shortcomings. From the perspective of law, the achievements we have made are summarized, the shortcomings are analyzed, and corresponding suggestions are put forward, in order to provide reference for further clinical trials regulation and the human subjects’ rights and interets. |
| Key words: drug clinical trials, human subjects’ rights and interests, law |
